Physician profile
Ronald M Blair
NPI 1356396691
$1,163.86
in general payments reported to CMS, 2019-2025
17 companies · $281 in 2025
The $281 reported for 2025 was more than what 83% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.33 · 2020: $85.57 · 2021: $150 · 2022: $170 · 2023: $121 · 2024: $258 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $241.91 | 2019-2025 | |
| Glaxosmithkline, LLC. | $235.43 | 2020-2025 | Bexsero |
| Cranial Technologies, INC | $136.94 | 2020-2025 | Doc Band |
| Seqirus USA INC | $96.17 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Sanofi-Aventis U.S. LLC | $83.78 | 2024-2025 | |
| Adlon Therapeutics L.P. | $76.38 | 2020-2021 | |
| Tris Pharma INC | $57.01 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $51.95 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $45.67 | 2022-2025 | M-M-R II, Gardasil, Gardasil 9 |
| Sanofi Pasteur INC. | $28.88 | 2025 | |
| Genentech USA, INC. | $27.42 | 2019-2020 | |
| Verrica Pharmaceuticals INC. | $19.49 | 2024 | Ycanth |
| Abbvie INC. | $18.28 | 2019 | |
| Ironshore Pharmaceuticals INC. | $16.53 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.17 | 2025 | Zoryve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hospira, INC. | $11.85 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Blair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.